Lomaira

Active Ingredient(s): Phentermine Hydrochloride
FDA Approved: * September 12, 2016
Pharm Company: * AVANTHI INC
Category: Diet / Weight Loss

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Lomaira Overview

Phentermine (phenyl-tertiary-butylamine), sold under the brand name Ionamin among others, is a medication used together with diet and exercise to treat obesity.[3] It is taken by mouth for up to a few weeks.[3] After a few weeks the beneficial effects no longer occur.[3] It is also available as the combination phentermine/topiramate.[5] Common side effects include a fast heart beat, high blood pressure, trouble sleeping, dizzine...

Read more Lomaira Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Phentermine

Recent Lomaira Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Phentermine Hydrochloride
  • Capsule: 15mg, 18.75mg, 30mg, 37.5mg
  • Capsule, Extended Release: 15mg, 18.75mg, 30mg
  • Tablet: 30mg, 37.5mg, 8mg
  • Tablet, Orally Disintegrating: 15mg, 30mg, 37.5mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Lomaira: (2 results)

Sorted by National Drug Code
  • 10702-001 Lomaira 8 mg Oral Tablet by Kvk-tech, Inc.
  • 63629-7874 Lomaira 8 mg Oral Tablet by Bryant Ranch Prepack

Other drugs which contain Phentermine Hydrochloride or a similar ingredient: (14 results)




Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 18 September 2019.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA